Scopulariopsis brevicaulis, a Fungal Pathogen Resistant to Broad-Spectrum Antifungal Agents

ABSTRACT The antifungal susceptibility results for 32 clinical isolates of Scopulariopsis brevicaulis are presented. Flucytosine and itraconazole were inactive in vitro, and MICs of amphotericin B, voriconazole, and terbinafine for all isolates were high, with geometric means of 13, 25.8, and 14.4 μg/ml, respectively.

[1]  E. Mellado,et al.  Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi. , 2002, The Journal of antimicrobial chemotherapy.

[2]  Y. Sohara,et al.  Scopulariopsis fungus ball. , 2002, The Annals of thoracic surgery.

[3]  D. Vittecoq,et al.  Recurrent subcutaneous infection due to Scopulariopsis brevicaulis in a liver transplant recipient. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  J. Guarro,et al.  In Vitro Antifungal Susceptibilities ofScopulariopsis Isolates , 1999, Antimicrobial Agents and Chemotherapy.

[5]  Elizabeth M. Johnson,et al.  In Vitro Activity of Syn-2869, a Novel Triazole Agent, against Emerging and Less Common Mold Pathogens , 1999, Antimicrobial Agents and Chemotherapy.

[6]  A. Wildfeuer,et al.  In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin , 1998, Mycoses.

[7]  T. Starink,et al.  Granulomatous skin infection caused by Scopulariopsis brevicaulis. , 1998, Journal of the American Academy of Dermatology.

[8]  D. Denning,et al.  Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. , 1997, The Journal of antimicrobial chemotherapy.

[9]  R. E. Kalina,et al.  Posttraumatic fungal endophthalmitis resulting from Scopulariopsis brevicaulis. , 1997, Retina.

[10]  B. Piraccini,et al.  Onychomycosis due to Scopulariopsis brevicaulis: clinical features and response to systemic antifungals , 1996, The British journal of dermatology.

[11]  R. Migrino,et al.  Deep tissue infections caused by Scopulariopsis brevicaulis: report of a case of prosthetic valve endocarditis and review. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  B. Lytle,et al.  Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis. , 1995, The Annals of thoracic surgery.

[13]  L. Gentry,et al.  Scopulariopsis endocarditis associated with Duran ring valvuloplasty. , 1995, Texas Heart Institute journal.

[14]  A. Lotery,et al.  Fungal keratitis caused by Scopulariopsis brevicaulis: successful treatment with topical amphotericin B and chloramphenicol without the need for surgical debridement. , 1994, The British journal of ophthalmology.

[15]  J. Dhar,et al.  Scopulariopsis brevicaulis skin lesions in an AIDS patient. , 1993, AIDS.

[16]  V. Morrison,et al.  The Spectrum of Non-Candida Fungal Infections following Bone Marrow Transplantation , 1993, Medicine.

[17]  R. C. Summerbell,et al.  Onychomycosis, Tinea Pedis and Tinea Manuum Caused by Non‐Dermatophytic Filamentous Fungi Nicht‐Dermatophyten‐Fadenpilze als Erreger von Onychomykosen, Tinea pedis und Tinea manuum , 1989, Mycoses.

[18]  G. Phillips,et al.  Invasive hyalohyphomycosis caused by Scopulariopsis brevicaulis in a patient undergoing allogeneic bone marrow transplant. , 1989, Diagnostic microbiology and infectious disease.

[19]  J. Neglia,et al.  Invasive Scopulariopsis in the immunocompromised host. , 1987, The American journal of medicine.

[20]  L. Wheat,et al.  Opportunistic Scopulariopsis pneumonia in an immunocompromised host. , 1984, Southern medical journal.

[21]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.